Inspire Medical raises FY25 EPS view to $2.20-$2.30 from $2.10-$2.20

Consensus $2.16. Backs FY25 revenue view $940M-$955M, consensus $949.17M. The company said, “Inspire is maintaining its full year 2025 revenue guidance of between $940 million to $955 million, which represents growth of 17% to 19% over full year 2024 revenue of $802.8 million. The company is maintaining its full year 2025 gross margin guidance of 84% to 86%. Inspire is increasing diluted net income per share guidance for the full year 2025 to between $2.20 to $2.30. This compares to the prior guidance of $2.10 to $2.20 per share.”